683 Capital Management »

Cartesian Therapeutics shares owned by 683 Capital Management

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4M 230k 10.22
2025-06-30 $2.3M 219k 10.39
2025-03-31 $2.0M 150k 13.18
2024-12-31 $2.2M 125k 17.91
2024-09-30 $1.2M 75k 16.12

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Cartesian Therapeutics

FMR
BlackRock
Siren
Vanguard Group
MPM Oncology Impact Management
Erste Asset Management GmbH
Geode Capital Management
683 Capital Management
State Street Corporation
Susquehanna International
Northern Trust
Citadel Advisors
GSA Capital Partners
Marshall Wace
Royal Bank of Canada

View all funds holding Cartesian Therapeutics